Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Jul;22(1):5–8. doi: 10.1128/jcm.22.1.5-8.1985

Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

P H Gilligan, P A Gage, L M Bradshaw, D V Schidlow, B T DeCicco
PMCID: PMC268309  PMID: 4019742

Abstract

A new medium for the isolation of Pseudomonas cepacia from respiratory tract secretions of patients with cystic fibrosis (CF) is described. This medium consists of inorganic salts, 0.5% pyruvate, and 0.1% proteose peptone as nutritive components and 0.0001% crystal violet, 0.15% bile salts, 100 micrograms of ticarcillin per ml, and 300 U of polymyxin B per ml as selective agents. The medium, designated PC medium, supported superior growth of 38 of 50 stock isolates of P. cepacia after 48 h of incubation when compared with MacConkey agar (0 of 50). The medium completely inhibited the growth of 112 of 124 stock isolates of organisms commonly found in respiratory secretions of CF patients. Cultures were made on PC medium with respiratory secretions of 169 CF patients. P. cepacia was recovered from 35 patients with isolates on PC medium but from only 21 patients with isolates on MacConkey agar. Of 221 other potentially pathogenic isolates found in these specimens, only six (two Pseudomonas aeruginosa isolates, two molds, one yeast, and one Serratia marcescens isolate) grew on PC medium. PC medium should facilitate the recovery of P. cepacia from CF patients.

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltimore R. S., Radnay-Baltimore K., von Graevenitz A., Dolan T. F. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. Helv Paediatr Acta. 1982;37(6):547–554. [PubMed] [Google Scholar]
  2. Carson L. A., Favero M. S., Bond W. W., Petersen N. J. Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. Appl Microbiol. 1973 Mar;25(3):476–483. doi: 10.1128/am.25.3.476-483.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Craven D. E., Moody B., Connolly M. G., Kollisch N. R., Stottmeier K. D., McCabe W. R. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med. 1981 Sep 10;305(11):621–623. doi: 10.1056/NEJM198109103051106. [DOI] [PubMed] [Google Scholar]
  4. Geftic S. G., Heymann H., Adair F. W. Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride. Appl Environ Microbiol. 1979 Mar;37(3):505–510. doi: 10.1128/aem.37.3.505-510.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilardi G. L. Pseudomonas species in clinical microbiology. Mt Sinai J Med. 1976 Nov-Dec;43(6):710–726. [PubMed] [Google Scholar]
  6. Gold R., Jin E., Levison H., Isles A., Fleming P. C. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):331–336. doi: 10.1093/jac/12.suppl_a.331. [DOI] [PubMed] [Google Scholar]
  7. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  8. McKevitt A. I., Woods D. E. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol. 1984 Feb;19(2):291–293. doi: 10.1128/jcm.19.2.291-293.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stover G. B., Drake D. R., Montie T. C. Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia. Infect Immun. 1983 Sep;41(3):1099–1104. doi: 10.1128/iai.41.3.1099-1104.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Thomassen M. J., Klinger J. D., Badger S. J., van Heeckeren D. W., Stern R. C. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr. 1984 Mar;104(3):352–356. doi: 10.1016/s0022-3476(84)81094-x. [DOI] [PubMed] [Google Scholar]
  11. Wood R. E. Cystic fibrosis: diagnosis, treatment, and prognosis. South Med J. 1979 Feb;72(2):189–202. [PubMed] [Google Scholar]
  12. Wu B. J., Thompson S. T. Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate. Appl Environ Microbiol. 1984 Oct;48(4):743–746. doi: 10.1128/aem.48.4.743-746.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES